Provider

By Jonah Comstock August 8, 2017
iRhythm Technologies, maker of the ZIO patch peel-and-stick heart monitor, announced on its second quarter earnings call that it increased its revenue 52 percent year over year (for a total revenue of $23.9 million) and achieved its first cash flow break-even quarter. CEO Kevin King also shared a rough timetable for the company's forthcoming Zio AT product, which received FDA clearance in June....
By Jeff Lagasse August 8, 2017
Kavya Kopparapu might be considered something of a “whiz kid.” After all, she had yet to enter her senior year of high school when she started Eyeagnosis, a smartphone app and 3D-printed lens that allows patients to be screened for diabetic retinopathy with a quick photo, avoiding the time and expense of a typical diagnostic procedure.   In June 2016, Kopparapu’s grandfather had recently been...
By Jeff Lagasse August 7, 2017
Backed by $28 million in investment, Israeli biotech company Art Medical, which detects and prevents life-threatening complications in intensive care units, is introducing a new platform that collects comprehensive patient data using sensor-based smart tubes, which will be utilized to reduce the risk of medical complications.   The smart tube technology uses sensors to collect data, and adjusts...
By Jonah Comstock August 7, 2017
Veritas Genetics,a leader in whole-genome sequencing, has acquired computing and bio-informatics firm Curoverse for an undisclosed amount. Curoverse provides infrastructure for life sciences companies to manage large datasets, including an open source platform called Arvados. The acquisition isn't totally unexpected, since the two companies have a strong existing relationship. Not only were both...
By Jonah Comstock August 7, 2017
The University of North Carolina is tapping Google's Verily Life Sciences and MindStrong (the company for which Dr. Thomas Insell recently left Verily) for an ambitious 19-site study of post-traumatic stress disorder. The study, called the Aurora Study, is funded by a $21 million NIH grant and aims to enroll 5,000 people. Aurora was launched last September and has sought private funding to...
By Jeff Lagasse August 7, 2017
One problem with sensors that derive information from sweat is that the patient being tested has to actually sweat. Oftentimes this entails exertion or room temperatures that run the gamut from impractical to unsafe. But thanks to Eccrine Systems Inc., testing sweat may soon become both easier and safer.   Founded by University of Cincinnati professor Jason Heikenfeld, Eccrine Systems has...
By Jonah Comstock August 4, 2017
A lot of people think Google Glass, the tech company's experiment with augmented reality and wearable computing, died when the Glass Explorer program closed up shop in 2015. In fact, the technology has continued to find a home with enterprise applications, particularly in healthcare. Indianapolis-based Hodei Technology is bringing Glass to hospitals in two different ways: as a tool for surgeons...
By Jonah Comstock August 4, 2017
Teladoc CEO Jason Gorevic certainly had a lot to talk about on yesterday’s Q2 earnings call. Referencing the recent legislation in Texas and the company’s acquisition of Best Doctors, Gorevic called Q2 2017 "the most exciting quarter in the company's history”. On the call, Gorevic delved into some details about how Teladoc and best Doctors will integrate, shared some future plans for the company...
By Tom Sullivan August 4, 2017
President Trump and Veterans Affairs Secretary David Shulkin, MD, on Wednesday introduced a new app, part of a plan to build out telehealth tools and services for veterans, and foretold rules that would make virtual care more accessible. Trump said the VA, along with the American Office of Innovation, which his son-in-law Jared Kushner runs, are working to improve care transitions between the...
By Jonah Comstock August 3, 2017
DexCom hasn’t been shy about its plan for opening up the CGM market by encouraging CGM use in a wider group of people with diabetes — including, eventually, people with Type 2 diabetes. On its second quarter earnings call, the company went deep on that focus on the future. “More and more people with diabetes are adopting CGM that as the primary tool to manage their condition, especially as we...